You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Use SHIFT+ENTER to open the menu (new window).
Follow
PHE Home
Currently selected
Preparedness
International Preparedness and Response
Southern Caucasus Collaboration and Partnership in Countering Biological Threats
Outbreak Response and Bioterrorism Investigation Trilateral Forum
Countering Biological Threats
North American Plan for Animal and Pandemic Influenza
U.S. Health Security National Action Plan: Strengthening Implementation of the International Health Regulations
Medical Countermeasures
HHS Retrospective on the 2009 H1N1 Influenza Pandemic
PHEMCE
Redirect to Strategic Planning and Committees on ASPR.HHS.gov
BARDA Funds Medical Countermeasure Innovation
HHS Centers for Innovation in Advanced Development and Manufacturing
BARDA evaluates burn dressing for radiation, sulfur mustard burns
BARDA funds study of therapy for thermal burns
HHS explores new emergency response use for approved steroid
HHS funds development of freeze-dried platelets for disaster response
BARDA funds development of device to aid burn patients in disasters
New blood test would provide fast results for medical care after anthrax attack
BARDA boosts global ability to respond to pandemics
New diagnostic test to detect the presence of an influenza virus and identify its genetic profile
New device could reduce time needed to test for bacteria, such as anthrax
Mass decontamination research provides new scientific evidence for responders, hospitals to decontaminate chemical terrorism, accident survivors
HHS pursues fast, easy test for anthrax and multi-drug resistant anthrax infections
BARDA funds advanced development of drug to treat injuries from exposure to cyanide
BARDA supports development of antitoxin administered as a traditional shot
BARDA funds development of drugs to treat injuries from chemical bioterrorism
Legal Authorities
Boards and Committees
Guidance
Pandemic and All Hazards Preparedness Act (PAHPA)
Public Readiness and Emergency Preparedness (PREP) Act
Redirect to About 1135 Waivers
Redirect to Public Health Emergency Declaration Q&As on ASPR.HHS.gov
National Biodefense Strategy
Evolution of U.S. Biodefense Policy
Redirect to Goals and Objectives
Redirect to Biodefense Strategy FAQs
Redirect to Biodefense Strategy Resources
About ASPR
BARDA
Redirect to Project Bioshield
ASPR 2020 Year in Review
ASPR Careers
Office of Acquisitions Management, Contracts & Grants
BARDA Broad Agency Announcement
Program Offices & Leadership
ASPR Program Offices
Redirect to Dawn O'Connell on ASPR.HHS.gov
Redirect to Nikki Bratcher-Bowman on ASPR.HHS.gov
Redirect to Leadership Bio: Jonathan Greene on ASPR.HHS.gov
Redirect to Leadership Bio: Gary L. Disbrow on ASPR.HHS.gov
Strategic National Stockpile
Federal Medical Stations
SNS and the COVID-19 Response
CHEMPACK
sustaining
products
imats
Emergency-Preparedness-and-Response
Lisa-Dillard
Steve-Adams
about
responses
training
Global Responders
Redirect to aspr.hhs SNS Course Listings
ESAR-VHP
SuccessStories
DesertMarathon
H1N1-RI
HurricaneIrene
KansasTornado
National Advisory Committee on Children and Disasters Redirect
COVID-19 Monoclonal Antibody Therapeutics QR Code
COVID-19 Vaccine Workforce
COVID-19: 2019 Novel Coronavirus Disease
Critical Infrastructure Protection for the Healthcare and Public Health Sectors Redirect
Redirect to the HPH RISC Toolkit
Emergency
Responder Tools and Resources
EPAP Redirect
Medical Reserve Corps
National Advisory Committee on Individuals with Disabilities and Disasters
National Advisory Committee on Seniors and Disasters
NDMS Help Desk
Recovery Redirect
Redirect for COVID-19 Resources for Pediatric Healthcare Leaders and Clinicians
Redirect to Aligning Health Care Industry Security Approaches
Redirect to COVID-19 Website
Redirect to Veklury
Home
SNS Redirect
The HHS emPOWER Map
default4
Site Contents
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
S3 Home
Biorisk Management
Biocontainment
Biosafety
Biosafety Stewardship
Biosecurity
Dual Use
Law & Policy
Currently selected
Boards and Committees
Federal Committees
Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA
Regulations
United States Laws and Codes
Executive Orders
Presidential Memoranda
Presidential Directives
Guidance & Guidelines
International Agreements
About Us
Newsletter
National Biosafety Month 2017
Site Contents
Lists, Libraries, and other Apps
Documents
0 items
Modified 12 months ago
Images
4 items
Modified 12 months ago
Pages
10 items
Modified 12 months ago
Workflow Tasks
0 items
Modified 5 years ago
Subsites
Boards and Committees
Modified 12 months ago
Federal Committees
Modified 12 months ago
Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA
Modified 12 months ago
